ClinicalTrials.Veeva

Menu

Pulmonary Arterial Hypertension in Systemic Sclerosis

I

IRCCS Policlinico S. Matteo

Status

Unknown

Conditions

Systemic Sclerosis
Pulmonary Arterial Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT00617487
EchostressSSc

Details and patient eligibility

About

The purpose of this study is to evaluate the role of stress echocardiography, compared to standard echocardiography in the early identification of pulmonary arterial hypertension in systemic sclerosis. To evaluate the role of BNP in this setting.To analyze data recorded with respect to the parameters commonly used for SSc evaluation (eg thorax HRCT, pulmonary function tests + DLCO, nailfold capillaroscopy, etc); these parameters are available starting for 1999.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with systemic sclerosis according to LeRoy criteria

Exclusion criteria

  • Pregnancy
  • Significant valvular disease
  • Low left ventricular function upon echocardiography (ejection fraction<55%)
  • History of atrial fibrillation, myocardial infarction, pulmonary thromboembolisms, neoplasia or severe hepatic disease.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems